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Tissue hypoxia is a characteristic feature of malig-
nant tumors and healing wounds, conditions that are 
associated with angiogenesis and with increased ex-
pression of vascular permeability factor (VPF; also 
called vascular endothelial growth factor, VEGF), a 
selective endothelial cell 11.1itogen inducing micro-
vascular hyperpermeability ill vi"o. We investigated 
the regulation of VPF/VEGF and its receptors by 
tissue hypoxia in normal human skin explants and in 
cultured skin cells ill vitro. VPF/VEGF mRNA expres-
sion was dramatically upregulated in epidermal ke-
ratinocytes, dermal fibroblasts, and dermal microves-
sels after 24 h of skin organ culture. Hypoxia also 
enhanced the expression of VPF/VEGF in cultured 
epidermal keratinocytes and dermal microvascular 
endothelial cells (predominantly VPF/VEGF121 and 
VPF/VEGFJ6S) and in dermal fibroblasts (additional 
T issue hypoxia is a characteristic feature of healing wounds, malignant tumors, and sevcral other non-neoplastic pathologic conditio ns that are associated with angiogenesis and increased micwvascl~lar pe~­mcability (Dvorak, 1986). There is IJ1crcasmg eVI-
dence that hypoxia itsc lfleads to the formation of new blood vessels 
and to vasculal' leakage, very likc ly by stimulatin g the synthesis and 
release of angiogcn ic factors (Knighton et nl, 1983; Kinasewitz el nl, 
1986; Adair ct nl,1990). One likely candidate for the m edia tion of 
hypoxia-induccd vascular alterations is vascular permea bility f.1ctor 
(VPF), also known as V'lscular endoth clial growth facto r (VEGF). 
VPF/VEGF is a 40- to 45-kD3 glycosylated cytokine that potently 
and selective ly cnhances microvascular endothelial cell prolifera-
tion (Ferrara and H cnzel, 1989; Gospodarowicz ef nl, 1989; Detmar 
et aI, 1995) and mi gl'a ti o n (Scnger et nl, 1996) ill vitro. Itl /1;VO, 
VPF/VEGF indu ces ang iogcncsis (Connolly CI aI, 1989; Keck cf nl, 
1989; Leung cf nl, -1989) and grcatly increa ses microvascular 
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upregulation ofVPF/VEGF189). The expression of the 
VPF/VEGF receptor Flt-l was selectively induced on 
dermal microvessels in skin explant cultures and in 
dermal endothelial cell monolayer cultures under 
hypoxic conditions. In contrast, the KDR receptor 
was downregulated by hypoxia. These results suggest 
that hypoxia likely regulates cutaneous angiogenesis 
and nllcrovascular permeability by two distinct mech-
anisms: (i) Induction of VPFIVEGF in epithelial and 
mesenchymal cells, including endothelial cells. (ii) Dif-
ferential modulation ofVPFIVEGF receptor expression 
by microvascular endothelial cells. These mechanisms 
may be of importance in the pathogenesis of healing 
wounds and some malignant tumors that are com-
monly characterized by hypoxia and overexpression of 
VPFIVEGF. Key IVords: elldotlwlial cellslallgiogellesisIFlt-1. 
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permeability (Senger et nl, 1983), a prominent feature of healing 
wounds and of malignant tumors. 
Expression of VPF/VEGF mRNA is uprcgulated above already 
high constitutive levels in the immediate vicinity of necrotic (and , 
therefore, hypoxic) regions of m an y human and anima.! tumors 
(Plate et nl, 1992; Shweiki et nl, 1992; Brown ct nl, 1993a, 1993b; 
Claffey et nl, 1996). VPF/VEGF is also overexpressed in severa l 
non-n eoplasti c pathologic conditions known to be associated with 
hypoxia; e.g., by epidermal keratinocytes in healing skin wounds 
(Brown ct nl, 19923) and by synovial cc Lls in rheumatoid arthritis 
(Fava el nl, 1994; Koch et nl, 1994). Furthermore tumor microves-
sels overexpress the mRNAs of both high-affinity VPF/VEGF 
receptors, Flt-l and KDR (Plate ct ai, 1992; Brown ct nl, 19933, 
1993b). Overexpression of both receptors also occurs in the 
proliferating microvascular endothelium in non-neoplastic condi-
tions associated with VPF/VEGF overexprcssion and hypoxia. 
Thus, we hypoth esized that skin , a tissuc composcd of an avascular 
epithelium (epidermis) with high metabolic demands and, there-
fore, a strong dependency on its vascularized stroma (dennis), 
might regulatc dermal microvascular endothelial cell function 
(permeability, proliferation) in response to hypoxia by modulating 
the expression of VPF/VEGF and/or its reccptors. To test this 
hypothesis , we cultured whule explants of normal human skin, as 
well as isola ted normal human epidermal keratinocytes, dermal 
microvascular cndothelial cells (HDMECs), and fibroblasts under 
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11 0 rmoxi c and h ypox ic conditions an d in vestigated th e exprcssio n 
of VPF/ VEGF an d its two reccptors, Flt-l and KDR. 
MATEIU ALS AND M ETH ODS 
Skin Explant Culture Freshl y co llected neonata l hum an fores kins were 
immerscd in icc-cold phosphate-bufre red saline at pH 7.4 and were cut into 
4-1ll11l squart.:s . Skin sam ples we re placed epiderma l side up in we ll s of 
24-wcll tissue culture clusters (Cos tar. Cambridge, MA) containing 1 1111 of 
Dulbecco's mod ified Eagle 's mediul1l . supplemented w ith H) 'Yo. fetal bovine 
serum (G IBCO BltL, Grand Island, NY). 2 mM t;lutal11ine. 100 units 
penicillin per ml , and 100 /-Lg streptom yc in per ml (a ll fro m Sigma, St. Louis, 
M O). Afte r cul ture fo r 24 h in a humidified incuba tor ill 5'Y" COo /95'X, 
ambient air at 37°C, explants were processed l'Or ;/1 s;I/I hybridi z;'ti o~, (see 
be low) . 
Cell Culture H DMEC were iso lated from hUlll an neonata l foreskins and 
propaga ted as described (Detmar CI al. 1992). Second-passage HDMECs 
were plated at 1 X 10" ce ll s per cm2 0 11 collagen-coated 100-mm plastic 
d ishes (Falcon . Becton-Dickinson. Lincoln Park , Nl ) in endothelial ce ll 
bas:d medium (C lonetics. San Diego. CAl . supplemen ted with 20% fe tal 
bovine se rum . ·1 /-Lg hydrocortisone ace tate pe r ml. 50 /-LM d ibu tyry l-cAMP, 
and antibiotics (S ib'!n a. St. Louis, MO) . At confluence. medium was 
aspirated . ;lI1d cul tures were washed twice with phosphate-bufFe red sa line 
and covered w ith endothe li al ce ll basal med iu m supplemented with 2% fetal 
bovine serum . After 24 h in 5(Y. COzl95% ambient air , cultures were 
incubated for an addi tional 4 o r 24 h under the sam e cond itions or were 
transferred to sealed chambers (1313L Cas Pack Plus system , Becton-
Dickinson. Lincoln Park. NJ) for add itio nal culture under hypoxic condi-
tions. T he BBL system depletes oxygen by mean S of a pa lladium cata lyst. 
Confluent second-passage hu man epide rmal ke ratin ocyte cultures derived 
£i'om neonatal foreskins (Detmar and O rf'l11 os, 1990) wcre cultiva ted in 
se rum- free ke ratinocyte basal medium (Cloncti cs, San Diego , CAl without 
furthe r supp lements and subjected to hypox ia as descr ibed above. Human 
dc rmal fibrob lasts were isola ted fi'om neonata l fo reskins; confluent fo urth 
and fifth passage cultu res were cul tured in D ul becco 's modified Eagle 's 
medium with 2% feta l bovine serum and antibio ti cs and were subjected to 
hypoxia as described above. For ;/1 s;I/I hybrid ization. ce ll s were handled 
iden tica ll y except tha t they were cul tured on co ll agen-coated Lah-T ek 
chambers (N unc. Naperv ille. rL). 
III Si(II Hybridization kin explants were fi xed fo r 2 h in 4% para for-
Illaldehyde in phosphate-buffe red sal;nc. pH 7.4, at ' l.oC , immersed in 30% 
sucrose in phosp h;,te-b ufrered sa li ne. stored overn ight at 4°C , frozen in 
OCT compound (Mi les Diagnostics, Elkhart. IN) , and stored at -80°C. 
Six-micro meter frozen sections were subjected to ;/1 S;( /I hybridization (ISH) 
as described (llro wn c/ al. 1992b). C el l cultures were flxed fo r 30 mill in 4'Y., 
pa ratormaldeh yde and stored in 70'Y" etlwnol at 4°C . T he anti-sense 
sing le-stranded I<-NA probe for human VPF/ VEGF was transcribed [rom a 
pGEM-3Zf( + ) vector containing a 204-bp PCR fragment of VPF!VEGF 
mRNA coding sequence common to all known VPF/ VEGF sp li cing 
variants (Berse ('I (/1, 1992). T he anti-sense sing le- stranded RNA pro bes for 
loca liz ing the two VPF/ VEGF receptors, KDR and Flt-1, were synthesized 
and utili zed "s described (Brown ci nl, 1993a). 
Northern Blot Hybridization For extraction of tota l R.NA , cul tured 
cell s were lysed in 4 M guanid;niul1l thiocyanate and fu rther processed as 
described (Claffey d nl. 1992) . Aliquots of RNA (10 ILg) were electropho-
resed on 1% ag;lrose ge ls and blo tted on BiotrallS nylon membranes (ICN, 
Cos ta Mesa, C Al . Northern b lot hybridization was perform ed with cDNA 
probes that had been labeled by random priming with deoxycytidine 
5 '- [a-J2 Pjtriphosp hate. by using the Mu ltiprime DNA labeling sys tem 
(A Tll crsharn. Arlington l-lcights, IL) nccordi ng to the 111 i1 I1U fa cturc r 's instruc-
tions. The 546-bp human VPF/ VEGF cDNA has been prev io usly descri bed 
(Dennar cl nl, 1994). The cDNA prohes fo r Flt- I and KDR were ampli fled 
by PC R of human placen ta l eDNA (Qu ickC lone. C lontech, Pa lo Alto , 
CA l. by using primers that surrou nd" 2.446-kb frag ment from positions 
24 S to 269 1 of the human flt-1 eDNA sequence and a O.83-kb fragment 
from pos itio ns 1650 to 2480 of the human kdr cD NA sequence. Purifled 
products were loned into pT7 (NoVilgen. Madison, W I) by means of single 
adenos ine overh angs. C lones were verified by restriction endonuclease 
ll1 appin !; and by e lectro pho retic analysis of PC R. produc ts fi'om two pairs of 
intern al primers fo r each of the receptor fi·agmcnts. N orthern blo t bylwid-
iza tion with the ribosome-assoc iated p rote in cDNA , 36 13 4 (Ma .< iakowski (' I 
01. 1982) was used to demo nstrate equiva lent l<-NA loading. 
Ribonuclease Protection Assays A single-stra nded VP F/VEGF ribo-
probe w;,s prepared by ;/1 ,,;Iro trallScription of il J 77-bp fl'agment derived 
li'o m human VPF/ VEGF' H') eDN A and clo ned between the EcoR I and 
B(// /I H I sites o f p lasmid pGem3Zf( + ) (Promega. Mad ison. W I), by using the 
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F igure 1. Potent in-
duction of VPF/VEGF 
n1RNA expression in 
skin organ cuJt ure. ISH 
was pcrfornlcd 0 11 I1CQ Jl:l -
ta l human foreskin (A,B) 
and afte r 24 h of organ 
cul ture (C-F). (A,B) VPF! 
VEGF anti-sense ribo-
probe app lied to normal 
foreskin shows sparse la-
beling of epiderma l kera-
tinocytes . (C,O) In tense 
labeling of ep idermal ke-
ratinocytes , de rma l fibro-
blasts, and derrn;lI mi-
crovesse ls after 24 h of 
organ culture . (E, F) Con-
trol hybridization of an 
adjacent section w ith 
VPF/ VEGF sense ribo-
probe shows low back-
ground labe ling. Bri ght-
fl eld (A,C,E) and dark-
fIC ld (B,O,P) photomicro-
g raphs. SCtl le bar, 10 ILm. 
Ribopro be II kit (Prom ega , Madison, W I) in the presence of uridinc 
5'-[a -32Pltriphosphate (DuPont- NE N. Boston , MA). yie lding a 420-bp 
anti-sense VPF/ VEGF riboprobc . Total ce llu lar RNA was extracted /Tom 
con flu ent cultures as for Northern blot hybridization. Samples of RNA (5 
/-Lg each) were hybridi zed with J21'_labeled VPF/ VEGF ri boprobe and 
digested with RNase by using the RPA 11 Kit (Ambion, Austin , TX) 
accordin t; to the rnanuf.1cturer's protocol. As cono·ols. two 10-ILg aliq uots 
of yeast RNA were hybridized with the saJlle amo un t of la be led VPF/ VEGF 
riboprobe, with o r witho ut addition of RNase. T he hyb ridi zation products 
that were protected from nuclease digestion were separated on a 6% 
polyacrylamidc/8 M urea ge l. I<-NA Centu ry Marker T empla te (Ambion , 
Austin . TX) was used to generate transcrip ts of known size, wh ich se rved 
as molecular weigh t markers. T he expected sizes of the pro tec ted bands 
were 377 nucleotides (nt) for VPF/ VEGF ,H<j . 276 and 29 nt fo r VPFI 
VEG F' GS' and 144 and 29 n t fo r VI'F/ VEGF
, 2 1• An add itional prominent 
band. ""347 nt in size. was I resent onl y in samples that contained the 377-n t 
band and. most probably, arose b)' partial RNase digestion of an AU-nch 
reg ion o f the 377-bp hybrid . exactl y 30 nt fi'om one end of the protected 
fi·agment. 
R~ESULTS 
E nhanced Expression of VPF/VEGF mRNA in Skin Organ 
Culture Focal low-level express ion of VPF /VEG F ml~A was 
detecte d in th e e pide rmis of n o rmal n eon ata l fo reskin s by ill Sirll 
h y bridi zation , w h ereas de rma l ce ll s were n eg ative (F ig 1A,B) . 
These d ata agree w ith ;11 ";P" fll1din gs we prev iously reported in 
n ormal human adu lt body skin (Detmar ef (/1, '1994; Brown ef (/1 . 
1995). To determine w h e th e r h ypox ia mi gh t regul ate VPF/ VEGF 
expression in skin , foreski n explants were cul ture d fo r 24 h in 5% 
C 0 2 195(Yt , ambi e nt air and th Cll processed fo r ISH. C ulture of 
foreskin exp lants unde r normoxic condi tio ns mos t like ly results in 
substantia l h ypox ia for cell s more th an a few layers removed fro m 
the su r fa ce that a rc dependent o n difFu sio n fo r gas and nUll'i e nr 
e xchange , a lth o ug h tbe difFusio n of oxygen in explants m ay be 
markedly diife rent frol11 th at w hich occurs ill pipo. A fte ,' 24 h , 
explant c ul tures e xpressed g re a tly in c reased amo un t' of VPF I 
VEGF IllRNA thro u g h o ut th e e pidermis but m ax imall y in th e basal 
la yer (Fig 1C,D). M o rcover , stro n g labelin g fo r VPF/ VEGF 
mflNA w as fo und over d e rma l m ic rovascu lar e ndoth e li um and in 
dermal fi bro blasts (Fig lC,D). 
Differential Regulation of VPF/VEGF Receptors in Skin 
Organ Culturc As in n o rma l adult hum an skin (De tmar CI (/1. 
1 994) , the de rmal microvesse ls of n orma l neo natal foreskin ex-
pressed li ttle o r n o Flt- 1 mRNA (Fi g 2A,B) an d o nly sm ail 
amoun ts of KDR. mR..NA as dete rmine d b y lSH (Fig 3A,B) . Afte r 
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Figure 2. Induction 
ofFlt-lmRNA in skin 
organ culture. Local-
ization of the VPFI 
VEGF rcceptor. Flt-l. in 
fi'cshly co llected neolla-
tal hUlllan foreskill (A.B) 
and :!trcr 24 h of organ 
culture (C,D) by ISH. 
(A, B) Lack of labeling of 
denna l l11icrovesscls in 
Il o nnai foreski n with an-
ti-sense riboprobc for 
At- I. (C,O) Strong ex-
pression of Fit- I mRN A 
a ll dcrnla l Ini crovcsscls 
after 24 h of organ cul-
tllre. 13right-field (ri. C) 
and dark-field (B, D) 
photomicrographs. Scnle 
hal'. 10 J.L111. 
24 h in explant culture, Flt-1 mRNA was strongly expressed by 
dermal micro vesse ls (Fig 2C,D) but not by other skin cell s. This 
result is consisten t with earlier data reporting overexpression of 
F lt-l mRNAs in diseased skin and o the r tissues charac te tized by 
tissue hypoxia (Plate el aI, 1992; Brown cl aI, 1993 a, 1993b, 1995) . 
In contrast to Flt-1, KDR mR.NA was undetectable in dermal 
microvessels after 24 h of culture (Fig 3C,D) . T hus, iu contrast to 
hypoxic states ill "i ,'o, hypoxia in skin expl ant cultures resu lted in 
upregula tion of Flt-1 but not KDR. mR.NA exp ress io n . 
A lthoug h valuable as a m e thod of preservin g the epidermal-
den11a l re lati o nships of intact skin , the th ickn ess of explants (> 1 
m.m) is such as to gen erate gradients of o xygen and other gases and 
of both nutrie nts and waste products. As a result, it is not poss ible 
to determine the precise concentratio n of oxygen, or of any other 
nutrient or waste product, in the dermi s or epidermis. Therefore, to 
test the regulatory role of hypo x i:! on th e express ion ofVPF/VEG F 
an d its recepto rs furth er, w e isolated and cultured several of the 
major ce ll types that make up normal skin under condi tions that 
permitted precise definition of extrace llul ar oxygen co ncentration. 
Hypoxia Induces VPF/VEGF Expression in Epidermal Ke-
ratinocyte Cultures ConAuent 1110nolayers of epidermal kera-
tinocytes were cultured for 4 or 24 It in basal medium under 
nonnoxic conditions (= 2 '1 % 0 2) o r were subj ected to hypox ic 
culture induced by a palladiull1 catalyst (= 2% 0 2; Kourembana s cl 
aI, 1990) . Keratin ocytes expressed on ly small amou nts of VPFI 
VEGF mRNA unde r norl11oxi c conditions (Fig 4) ; in contrast, 
h ypoxia markedly upreg ulated V P F/VEGF mRNA expression as 
early as 4 It aJld induced a more than 10-fold increase by 24 h (Fig 
4). Control cul tures sho wed a sli gh tly enhanced VPF/VEG F ex-
pression after 24 h , as compared to 4 h . T his difl:crence might be 
Figure 3. Downregu-
lation of KDR mRNA 
expression in skin or-
gan culture. (A ,B) Weak 
labeling of demlal m;cro-
vessels ill nOl"lnal fores kill 
with anti-sense riboprobe 
for KDR. (C, O) Lack of 
labeling after 2~ h of organ 
culture. Bright-field (A,C) 
alld dark-field (B,O) pho-
tomicrographs. Scale bnr, 
10 J.Ln1. 
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Figure 4. Induction ofVPF/VEGF mRNA expression in HDMECs, 
epidermal keratinocytes (EKCs), and dermal fibroblasts (DFBs) by 
hypoxia. Northern blot anal)'sis of tota l RNA (1 0 J.Lg per lan e) extracted 
Ii'olll conAuent HDMEe. EKe, or DFfl cultures incubated for 4 h or 24 h 
under normoxic (e) or hypoxic (0 2) condi tions. Addition of anti-EGF 
reccptor antibody did not inhibit VPF/ VEGF induction in keratinocytcs . 
T he positions of 28S and 18S r1~A species are indicated. T he blot was 
hybridized with a VPF/ VEGF eDNA probc. The 285 bands on the original 
gel demonstrate equiva lell t RNA loading. 
due to diffe rent degrees of conflu en ce of epidermal keratinocytes 
and/or to the lon ger time pe ri od sin ce the last m edium chan ge. 
We have previously shown that transfon11ing g rowth factor-a 
reacts with the keratinocyte epidermal growth facto r receptor to 
upregu late the expression of Vl)F / VEG F mRNA in cultured kera-
tinocytes (Detmar el aI, 1995) . To determin e whether hypoxia 
might be indu cing VPF/ VEGF mRNA express ion by sim il arly 
lIpI'egulating transforming growth hl ctor-a express io n, we m ade 
use of a ne utra liz in g antibody aga inst the epidermal growth facto r 
receptor that abolished the ability of transfon11in g growth factor-a 
to upregulate VPF/VEGF mRNA expression in keratinocytes 
(Detmar el aI, 1994) . T he hypoxia-induced express io n of VPFI 
VEGF was unaffected by addition of th e n eutraliz ing anti-epidermal 
growth f;lc tor receptor antibody (Fig 4) ; therefore , the upregula-
tion of VPF/VEGF mRNA observed wlder hypoxic culture con-
di tions ca nnot be attributed to th e intermediary activity of trans-
form in g growth factor- a o r other facto rs that bind to the epidermal 
g rowth facto r receptor such as heparin-binding epidermal growth 
f.'1ctor or amphiregu lul . The heavy meta l cobal t chlo ride supposed ly 
inte rac ts w ith a putative heme-binding oxygen sensor in m amma-
lian cell s and indu ces the same effects on gene expression as hypoxia 
(Go ldberg cl aI, 1988) . Additio n of cobalt chloride (100 f-LM) to 
cultured keratinocytes also led to enhanced VPF/VEGF mRN A 
expression (data not shown) , supporting a direct stimu lation of 
VPF/VEGF expression by hypoxic conditio ns. 
T he VPF/VEGF tamil y includes at least four re lated peptides that 
arise £i'om alte rnative mH . .NA splicin g of a sin gle gene (Ferrara c ( nl, 
199 1). By using the ribonu clease pro tection assay with a VPFI 
VEG F I ~'Fderived riboprobe, w e were able to distinguish am on g 
the three most common VPF/VEGF splic ing variants , VPFI 
VEGF , 2 1, VPF/VEG F , 6 5 , and VPF/ V EGF , 8 " . Hypox ia indu ced 
keratu10cytes to express predominantly the two lower molecular 
w eight isoforms , VPF/ VEGF
, 2 , and VPF/VEGF ,c•5 (Fig 5). En-
hanced VPF/ VEGF express ion by hypox ic keratin ocytes a lso led to 
enh anced secre tion ofVPF/ VEGF protein into the culture medium 
(LIp to 2-fold after 24 h ; data not shown), as measured by a two-s ite 
time-resolved immunofluorometric assay (Detmar cl aI, 1994) . 
VPF/VEGF secre ted by epidermal kerati nocytes was bio logical-
ly active, as m easured b y the mi togenic e fl:ect of keratinocyte-
conditioned m edium on HDMECs, w hich was inhibited after 
depletion of VPF/ VEGF fi'om the condi tioned m edium. 
Hypoxia Induces VPFIVEGF mRNA Expression in HDMECs 
and in Dermal Fibroblasts I-IDMEC m o nolayers expressed 
very low levels ofVPF/VEGF mRNA in n ormoxic cultures but did 
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Figure 5. Ribonuclease protection assa y of total RNA demon-
stra tes induc tion ofmRNAs for VPF/VEGF '2I and VPF/VEGF'65 in 
epidermal ke ra tinocy tes (EKCs) and HDMECs by hypoxia. Hypoxia 
add itionally indu ced mRNA fi,r VPFIVEG F, H9 in dermal fibrobl;, sts 
(DFlls) . Strong express ion of all three I11R.NA isoforl'l1 s in the control 
fibrosa rcoma line HT- IOBO. Yeast I"tNA, with (+ ) or without (- ) addition 
of R N ase , se rved as contro l. 
ex press m odest am o un ts of ml~NAs e ncodin g the two sm all e r 
VPF/ VEGF isofo rm s afte r c ul ture fo r 24 h under hypox ic condi-
tions (Figs 4,5) : th ese fi ndin gs are consisten t w ith the re po r ted ill 
IIilm VPF/ VEGF ml~A exp ress io n ill so m e endo the li al cells 
deri ved fi 'o m othe r o rgans (Weind e lI'! nl, 1992; Lado ux and Fre lin, 
1993a; Uchida el nl, 1994) and w ith the upregula ti o n of VPF/VEG F 
mI~NA express io n by de rmal I11jc rovessels in fo reskin expl ant 
cultures (Fig 1). H ypox ia al so induced VPF/ V EG F mlWA in 
de rmal fi b ro bl asts; expressio n was consistentl y g reater than that 
induced ill H D M E s but less than th at induced in keratin ocytes 
(Fig 4) . ll1 con trast to ke ratinocytes and H D M ECs, fibro bl as ts also 
expressed inc reased am o unts of the mlWA tha t e ncoded VPFI 
VEGF , R~' a predomin antl y cell -associated VPF/VEGF isofo rm (Fig 
5) . 
H y poxia Diffe~entially Regulates VPF/VEGF Receptors in 
HDMEC Like their co un te rpar ts in n o rmal skin, HDMECs ex-
pressed o nl y sm a ll am o unts o f Flt-1 mRNA in nOl"moxic culture; 
howeve r, Fh·-1 mRN A express ion in creased m arkedly a fte r 24 h of 
hyp ox ic culture . No rth e m blot ana lys is revealed three majo r bands 
w ith predomin ant upreguJati o n o f the 7 .5- to 8.0-kb do ubl e t (Fig 
6) bu t H DMEC d id n ot ex press the additi o n a l 2.7-kb band th at h as 
been described ill ao r ta - o r umbili ca l ve in- de ri ved endo thelial ce ll s 
(Ba rl eon et nl, 1994). N o rmoxic H D MEC cultures expressed 
substa ntial '1111 0 unts of ml~A cod ing fo r th e second VPF/VEGF 
receptor . KDR (Fig 6) . in contras t to the low level of KDR 
express io n in no rm al skin ill silll . Thi s diffe ren ce mig h t be due to the 
h ype rp ro life ra ti ve state of H D M EC ill II ilm, beca u se ang iogenic 
vesse ls in d iseased hum an skin arc also characte rized by increased 
express io n o f KD R (D e tma!" cl nl, 1994) . Afte r 4 h o f hypoxic 
c ul ture, KD R express io n was dow nregul ated by = 50'X" and afte r 
24 h of hypox ia . KD R ex press io n beca m e nea rl y undetecta ble (Fig 
6). Co n fi rma tio n o f these fi ndin gs w as o b ta ined by ill silll hybrid-
izatio n . H D M ECs di d not decrease il1l111mbc r a fte r 24 h of hypoxia, 
bu t the labe ling in ten sity of indi vidu a l cell s fo r KDR mRN A was 
redu ced substan tia ll y (F ig 7). 
D ISC U SS IO N 
In severa l impo rta n t exampl es o f skin patho logy (e.g., w o und 
h ea ling an d bull o us di seases w ith sube pide rmal bli ste r fo rmatio n), 
e pide rm al ke ratin ocytes overexpress VPF/ VEGF mRNA and de r-
m al mi crovascul ar e ndo the li a l ce ll s o ve rex press ml~NA s e ncoding 
bo th V PFIVEGF recep tors, Fl t-1 and KD R (Bro wn ci nl, 1992a, 
1995). Simi lad y, VPF/VEGF and its two recepto rs are concordantl y 
overexpressed in m a n y ani ma l and hum an tum o rs (Senger cl nl, 
1983; B e rkm an 1'1 nl, 1993 ; Se nger el nl, 1993 ; C laffey cl nl , 1996) , 
in cl ud in g sq ua m o us cell ca rc in o m as of th e skin (Bro wn cl nl, 
unpublished d ata) , and in chronic inflammato ry states suc h as 










Figure 6. H ypoxia differentially regulates the expression of 
HDMEC VPF/VEGF receptors. Northcl'll blot analys is of toro l J"tNA (10 
f.Lg per lane) extracted from confluent HDM ECs cultured fo r -I h and 2-1 h 
under norl11 oxic (e) or hypoxic (02 ) condi tions shows strong induction of 
Flt-1 expression after 24 h of hypoxia. The flt-l cD NA pro be hyb ridized 
with three mRNA specics of approx imately 8 .0, 7.5 kb (doubl et). and 3.4 
kb wi th predominant induction of the B.O- and 7.5-kb banek In COl1l"rast. 
expression of KD K mKN A was almost undetecta ble after 24 h of hypoxia. 
Control hybridi zation wi th ribosome-associa ted protein eD NA 36 B4 del11-
onstrates equi va lent I"tNA loading in all lanes. 
rhe umato id arthriti s (Fava el nl, 1994) . All of these condi tio ns are 
charac te t'ized by micro vascula r hype rperm ea bili ty, an giogenes is. 
and ti ssue hypox ia (Dvorak, 1986) . Becau se hypox ia indu ces 
VPFIVEGF mJWA syn thes is in several lin es o f cultured ce LIs 
(Shwe iki cl nl, 1992 ; Lado ux and Frelin. 1993 b; Brogi cl nl, 1994; 
Goldbe rg and Schn e ide r, 1994; Min ch enko el nl, 1994)' and 
becau se VPF/ VEGF expressio n in tum ors m ay be regul a ted a bove 
al.ready hi g h constitutive le ve ls immedia te ly adjacent to sites of 
n ecrosis (Shweiki c/ nl, 1992 ; Bro wn el nl, 1993a, 1983 b; Plate el ai , 
1993) , i t is at t rac tive to pos tulate that hyp oxia is respo nsible fo r 
inducing or furth e r enh ancing microvascular hype rpe rmea bility and 
an g iogen es is by upregul ating the express io n of VPFI V EGF and its 
rece p to rs . 
, Koos RD. O lso l1 CE: Hypoxia stimula tes cX'pn'ss ion of the gene for 
vascular endothelial growth factor (V EG F), " pu tative angiogcnic r.,ctor, by 
granulosa ce lls of the ovari an fo llicle, a site of angiogenesis. J Cell Bioi 
11 5:421.1 991 (abstr) . 
F igure 7. Hypoxia 
downregulates the 
expression of KDR 
mRNA in HDMECs. 
Loca liza tion of mR.NA 
for the VPFI VEG F re-
ceptor KDK in normox ic 
(A, B) and hypoxic (24 h) 
(C,D) H DMECs by ISH . 
Bright-field (A,C) and 
dark- fi eld (B,D) pho-
tomicrographs. Scale bar, 
10 f.Lm . 
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T he da ta presen ted he rein ofte r suppo rt fo r po rtio ns of this 
hypo thesis. T hu s, h ypox ia strikingly in creased ke ratinocyte expres-
sion of VPFI VEG F mRN A in skin ex pl ants and o f bio logicall y 
active VPF/V EGF in mo no layer cul tures; this is in accord w ith 
events occurring i/l I1 i l1o in wo und healing, som e bull o us diseases, 
and sq uamo us cell carcino mas (l3rown 1'/ fl l , ·1992a, 1995), sta tes 
that are chara cterized by hypoxia and substan tial keratinocyte 
overexpression o f VPF/ VEG F mRN A. H ypoxia also upregulated 
VPF/VEG I: expression in cultured delTnal fibroblasts and HDMECs, 
b ut to signifi cantl y diffe re nt extents: kerat i.l1ocytes > fibroblasts > 
e ndo thelial cell s. Alth ough o m prev io us investiga ti ons revealed 
that in the maj ority o f skin diseases studied , VPFI VEG F expression 
was predo min antly confined to epide rmal keratinocytes and som e 
infi ltra tin g inflamma tory cells, probabl y m acro phages (l3rown er fl l , 
1992a; Detmar 1.'/ fll , 1994; Brow n ('I til , 19(5), expression of 
VPF/VEGF by de rmal endothe lia l ce ll s mig ht occur under highly 
hypox ic conditio ns ill II i"" and migh t represent an autocrin e m ech-
a nism stimula tin g skin angiogenesis (Liu ('I fl l , 1995 ; NamiJ..."i el fll , 
1995). W e ca nn ot e xcl ude the possibili ty . ho wever , that injury 
m ight have contributed to the observed inducti on of VPF/ VEGF, 
in additi on to the e ffects o f hypoxia. 
VPF/ VEGF is expressed in several diffe rent isofo rlll s as the result 
of alterna tive gene splicing . H ypoxi c ke ra tinocytes primaril y syn-
th esized ml~As encoding VP F/VEGF ' 2' and VPF/VEGF , (,S' 
isoforms th at arc large ly secreted in solubl e form (Park eI fll, 1993 ). 
This makes sense in tha t cytokines secreted by keratinocytes must 
diffuse some dista nce- thro ug h se veral ce ll laye rs and a basa l 
lamina-to reach their ta rgets. recepto rs o n th e surface o f dermal 
vascular endothelium . In co ntrast. hypoxic fibro blasts expressed 
VP F/ VEGF ' K') in additio n to th e two smaller isofo rms; VPFI 
VEG F' 8~ remains large ly ce ll associated and IlIay se rve as a storage 
fo rm of VPF/VEG F o n the ce ll surhlce. readily acti va ted by 
p r o teolytic cl eavage (Park ci fl/ . 1. 9(3) . 
H ypox ia al so IIpr~r:IlI f1 / cd th e expressio n o f mRNA for th e VPFI 
VEGF recep tor Fit-I o n microvessel s in skin explam s and o n 
HDM EC m o no laye r cul tures; ho wever. hypo xia dOl/lllregll/ fl (('d 
HDM EC expressio n of th e second VP FI VEGF receptor KDR. W e 
conclude fi·o lll these data that low o xygen tensio n m ay contribu te 
to o r entirely account fo r the incre <l sed expression o f Flt-l o bserved 
in va rio us patho logic states associ;,ted with hypoxia (e.g .. tumors, 
wo und healin g, etc. ) . Low ox)'gen tension , ho wever, does not 
explain th e upregul ated KD R expressio n o bserved ill these sam e 
patho logies ill "il'O. T he refo re . addi tio nal stimuli have to be acti-
vated ;'1 IJirlO to induce KD R expression ill . e.g .. healing wounds . 
Al tbou gh both endo th e lial ce ll recepto rs, Flt- "l ;lIId KDR, bind 
VPF/VEG F wi th high affini ty, they can be difFe rentiated by their 
po tential to transmi t distinct bio logic e ffects of V1)F/VEG F o n 
endotheli al cells. Whil e KDR seem s to be responsible fo r tran s-
d u cing the mi togenic and permeabili ty enhan cing e ffects of VPFI 
VEGF (Park ('( nl , 1994), our preliminary evidence suggests that the 
Fl t-l recepto r is invo lved in th e stimula tio n of endo thelial ce ll 
migratio n. Pl acen ta growth facto r , a growth factor closely re la ted 
to VPF/ VEG F (Maglione ct fl l , 1991). w hich se lecti ve ly binds to the 
Flc-l recep to r on endo th eli al ce lls (Park el ai , 19(4), potentl y 
induces H D MEC migrati on .2 T he re fo re, hypox ic tissue conditions 
might, via differential regula tion o f the two receptors fo r th e 
angiogenic facto r VPFI VEGF. diffe ren tia ll y m odulate the an gio-
genic response in the skin , fa vorin g endo th elial ce ll mi gration over 
e ndothelial ce ll mi togenesis. 
T hus, these results dem onstrntc tha t VP F/ VEG F is a tIIaj ol· f.1ctor 
m e di ating angiogenesis and in creased microvascular permeability in 
h ypox ic skin and tha t h ypox ia regul ates both the expression o f 
VPF/VEGF and its receptors. In additio n to inflammatory and 
b listering skin diseases and hea lin g wounds. these findin gs yie ld 
new in sights into the tIIechani sm s that induce angiogenesis in 
2 Detmar M . Elicke r BM. J ackm'\11 R.\V. Brown LF. Senger D R. . Placenta 
growth facto r. a new m ember of the VI'F/ VEGF 1~I111 i l y. is expressed b y 
epjdenll nl kc ra tin oc)'tl!S alld de rrnal mi crovas<..: ul ar endo th e lia l cell s ;11 " iim 
and ;11 1/;1'0. J 1lI,/cst D I''''' lfll(,1 106:835. 1996 (absl"r) . 
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malignant tUl\1ors that are characterized both by tissue hypox ia and 
by increased e xpression of VPF/VEGF and its recepto rs. 
IV" th ll llk EJ. MII IISI'II I1 II l1d K. Tog ll azz; fiu· their excel/"/II tCc/l/lira l IIss;s/lIurt'. 
T his ,''v ,./' .. was s IIp p0l1ed by Dell tschi' Forsrltlllljf))}.cmtiw:cltnI' Grn" , Dl' 483 /3- 1, 
ii I' N nI;,,1I 111 Cmlet'" hlS/;lIl1e G ra llls CIl-69 184 " lid CA -64436, by (Ire Nat ;,," 111 
Pso,.ias;s FO lllldll l;!> II , by tire Nll r;o/ lIIl A lopecia A rentll P(l lIlIdnt;(l II , 111111 by (Ire Belh 
[smel Pnr/w /o.f!)' PO /flllintioll , fll c. 
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